Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study
D P Wales1, S Khan2, D Suresh2
1Albany Medical Center, Division of Internal Medicine/Pediatrics, 1019 New Loudon Road, Cohoes, NY, 12047, USA.
Insights
Maternal Tdap vaccination uptake was 65.8%. Provider recommendation and influenza vaccine receipt were associated with higher Tdap uptake in pregnant women. Encouraging general vaccine use can improve rates.
Area of Science:
- Obstetrics and Gynecology
- Pediatrics
- Public Health
Background:
- Pertussis poses a significant risk to infants, causing substantial morbidity and mortality.
- Despite recommendations for Tdap vaccination in pregnant women, uptake remains suboptimal.
- Infants under 1 year are disproportionately affected by pertussis, accounting for 70% of deaths.
Purpose of the Study:
- To assess factors associated with maternal Tdap (tetanus-diphtheria-acellular pertussis) vaccine uptake during pregnancy.
- To identify best practices for improving Tdap vaccination rates among pregnant women.
- To identify pregnant women at risk for not receiving the Tdap vaccine.
Main Methods:
- Retrospective cross-sectional study analyzing maternal-infant delivery records.
- Chi-squared and multivariate analyses were used to determine factors associated with Tdap uptake.
- Study included maternal-infant dyads admitted to Albany Medical Center from January 1, 2016, to April 16, 2016.
Main Results:
- Maternal Tdap vaccine uptake was 65.8% (n=400), with a median gestational age of receipt at 30 weeks.
- Positive associations with Tdap receipt included provider recommendation, maternal influenza vaccine receipt, and infant hepatitis B vaccine receipt.
- On-site availability of Tdap vaccine was also positively associated with maternal uptake.
Conclusions:
- Provider recommendation and concurrent influenza vaccination significantly increased maternal Tdap uptake.
- Encouraging overall vaccine usage and addressing vaccine hesitancy can improve Tdap rates.
- A potential association between Tdap receipt and assisted reproductive technologies warrants further investigation.
Objective:
Pertussis morbidity and mortality disproportionately affect infants younger than 1 year, who constitute 70% of deaths from pertussis. In 2017, 43% of infants younger than 6 months diagnosed with pertussis were hospitalized. In 2012, the Advisory Committee on Immunization Practices recommended that all pregnant women should receive Tdap (tetanus-diphtheria-acellular pertussis) vaccine between 27- and 36-weeks gestation in an effort to reduce infant pertussis morbidity and mortality. However, Tdap vaccination rates among pregnant women remain far from robust. The aim of this study was to assess factors associated with maternal Tdap uptake to help providers identify best practices that can improve Tdap receipt and identify women at risk for not receiving this important vaccine.
Study Design:
A retrospective cross-sectional study.
Methods:
A review of prenatal and delivery records was performed on all maternal-infant dyads with infants older than 36 weeks gestation admitted to the term nursery at Albany Medical Center from January 1, 2016 to April 16, 2016. A chi-squared analysis using STATA®, version 14.1, was performed to determine if any variables were associated with Tdap uptake, with statistical significance defined as P < 0.05. Multivariate analysis was performed to identify the variables which had the greatest effect on Tdap receipt.
Results:
Tdap vaccine was received by 65.8% of pregnant women (n = 400) in the study; median gestational age of receipt was 30 weeks. Maternal influenza vaccine receipt, infant hepatitis B vaccine receipt, provider recommendation of Tdap vaccination, and on-site availability of Tdap vaccine were all positively associated with maternal Tdap receipt during pregnancy.
Conclusion:
Receipt of Tdap by pregnant women was highest in those who had received a provider recommendation about its benefits and who also received influenza vaccine during pregnancy. Because women who received the influenza vaccine themselves and also consented to have their infants receive the hepatitis B vaccine had significantly higher uptake rates, encouraging vaccines usage and combating vaccine hesitancy in general can improve Tdap uptake rates. A small, but statistically significant association with receipt of assisted reproductive technologies was also seen, meriting future research.
Related Concept Videos
01:49Probability Laws
01:21Factors Affecting Drug Response: Overview
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:07Teratogenicity
01:29Therapeutic Drug Monitoring: Affecting Factors
01:51Vaccinations